Eli Lilly's Q2 Revenue Skyrockets by 38% to $15.56 Billion Amidst Breakthroughs in Oncology and Cardiometabolic Health

Eli Lilly and Company announced a 38% increase in Q2 revenue to $15.56 billion, with net income up by 91%. The company also highlighted advancements in its oncology and cardiometab...